Cel-Sci Corp Series S
CVM.WS
CVM.WS was delisted on the 8th of October, 2018.
2 hedge funds and large institutions have $0 invested in Cel-Sci Corp Series S in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less capital invested
Capital invested by funds: $185K → $0 (-$185K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$397 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$184K |
CVM.WS Hedge Fund Activity: Q3 2018 in Review
2 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cel-Sci Corp Series S (CVM.WS) for Q3 2018, worth a combined $0 — down 100% from $185K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CVM.WS and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest buyer was UBS Group, opening a new position worth an estimated $397. The largest seller was DZ Bank, exiting entirely with an estimated $184K sold.
- 2 institutional investors held Cel-Sci Corp Series S (CVM.WS) as of Q3 2018, down from 3 in Q2 2018.
- Funds reported $0 of Cel-Sci Corp Series S stock for Q3 2018, down 100% quarter-over-quarter.
- 1 fund opened new Cel-Sci Corp Series S positions in Q3 2018 and 2 closed out, a net change of -1 holder.
- The largest Cel-Sci Corp Series S buyer in Q3 2018 was UBS Group, an estimated $397 added.
- The largest Cel-Sci Corp Series S seller in Q3 2018 was DZ Bank, an estimated $184K sold.
Based on aggregated 13F filings for Q3 2018.